rs1017639

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001876.4(CPT1A):​c.-14+10709T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0645 in 152,264 control chromosomes in the GnomAD database, including 465 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.065 ( 465 hom., cov: 33)

Consequence

CPT1A
NM_001876.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.728

Publications

5 publications found
Variant links:
Genes affected
CPT1A (HGNC:2328): (carnitine palmitoyltransferase 1A) The mitochondrial oxidation of long-chain fatty acids is initiated by the sequential action of carnitine palmitoyltransferase I (which is located in the outer membrane and is detergent-labile) and carnitine palmitoyltransferase II (which is located in the inner membrane and is detergent-stable), together with a carnitine-acylcarnitine translocase. CPT I is the key enzyme in the carnitine-dependent transport across the mitochondrial inner membrane and its deficiency results in a decreased rate of fatty acid beta-oxidation. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CPT1A Gene-Disease associations (from GenCC):
  • carnitine palmitoyl transferase 1A deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001876.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.128 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001876.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPT1A
NM_001876.4
MANE Select
c.-14+10709T>G
intron
N/ANP_001867.2P50416-1
CPT1A
NM_001440358.1
c.-14+13079T>G
intron
N/ANP_001427287.1
CPT1A
NM_001440359.1
c.-14+8486T>G
intron
N/ANP_001427288.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPT1A
ENST00000265641.10
TSL:1 MANE Select
c.-14+10709T>G
intron
N/AENSP00000265641.4P50416-1
CPT1A
ENST00000376618.6
TSL:1
c.-14+10709T>G
intron
N/AENSP00000365803.2P50416-2
CPT1A
ENST00000867662.1
c.-14+2743T>G
intron
N/AENSP00000537721.1

Frequencies

GnomAD3 genomes
AF:
0.0643
AC:
9789
AN:
152146
Hom.:
462
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.122
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0225
Gnomad ASJ
AF:
0.0672
Gnomad EAS
AF:
0.0281
Gnomad SAS
AF:
0.136
Gnomad FIN
AF:
0.0323
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0422
Gnomad OTH
AF:
0.0521
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0645
AC:
9822
AN:
152264
Hom.:
465
Cov.:
33
AF XY:
0.0639
AC XY:
4755
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.123
AC:
5097
AN:
41548
American (AMR)
AF:
0.0225
AC:
344
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0672
AC:
233
AN:
3468
East Asian (EAS)
AF:
0.0280
AC:
145
AN:
5182
South Asian (SAS)
AF:
0.137
AC:
660
AN:
4820
European-Finnish (FIN)
AF:
0.0323
AC:
343
AN:
10622
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.0422
AC:
2868
AN:
68020
Other (OTH)
AF:
0.0525
AC:
111
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
467
934
1402
1869
2336
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0482
Hom.:
239
Bravo
AF:
0.0635
Asia WGS
AF:
0.102
AC:
358
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.10
DANN
Benign
0.29
PhyloP100
-0.73
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1017639;
hg19: chr11-68598534;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.